Spastic Diplegia Cerebral PalsyNCT07421505
Spinal Mobility in Children With Cerebral Palsy: NDT-Bobath and Exergaming
A study testing NDT-Bobath Therapy, Sitting Exergaming and Standing Exergaming in people with Spastic Diplegia Cerebral Palsy and Spastic Hemiplegia, run by Wroclaw University of Health and Sport Sciences at 2 sites in Poland.
Trial summary
The purpose of this study is to evaluate changes in spinal mobility in the cervical, thoracic, and lumbar regions in children with cerebral palsy aged 10-15 years. The study will compare outcomes between standard NDT-Bobath therapy supplemented with exergaming in a sitting position and exergaming in a standing… Read more about this study
- Who is it for?
- Ages 6 to 18 years
- Conditions the study is for
- Spastic Diplegia Cerebral Palsy, Spastic Hemiplegia
- What is being tested?
- NDT-Bobath Therapy, Sitting Exergaming and Standing Exergaming
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 42 participants
- Where
- 2 sitesPoland
- Study dates
- Feb 2026to Jun 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 6 to 18 years
- All sexes
- No healthy volunteers
- Child, Adult
Who may be able to join
- Written informed consent from parents/guardians and the child (if capable)
- GMFCS levels I-III (mild to moderate motor limitations)
- Ability to maintain standing position
- Ability to follow instructions and perform exercises
- No prior exergaming therapy
- No implanted electronic devices
- No acute infections or inflammatory conditions
- No metabolic disorders affecting bioimpedance measurements
Who cannot join
- GMFCS levels IV-V
- Orthopedic surgery within the past 12 months
- Seizure episodes within the past 6 months
- Cognitive or behavioral impairments preventing cooperation
- Severe spinal deformities (scoliosis >40° or other significant changes)
- Attendance at therapy sessions <85%
Trial locations and contacts
2 sites in 1 country. Contact the study team or a site near you to ask about taking part.
Poland2 sites
Specjalistyczne Centrum Medyczne im. Jana Pawła II S.A.
Polanica-Zdrój, Lower Silesian Voivodeship, 57-320
Aleksandra Kopaczyńska, Master of Science, +48601157773, aleksandra.kopaczynska@awf.wroc.pl
Aleksandra Kopaczyńska, Master of Science
Wroclaw University of Health and Sport Sciences
Wroclaw, Lower Silesian Voivodeship, 51-612
Aleksandra Kopaczyńska, Master of Science, +48601157773, aleksandra.kopaczynska@awf.wroc.pl
Aleksandra Kopaczyńska, Master of Science
About this study
Official title: Spinal Mobility in Children With Cerebral Palsy Undergoing NDT-Bobath Therapy and Exergaming-based Therapy
The purpose of this study is to evaluate changes in spinal mobility in the cervical, thoracic, and lumbar regions in children with cerebral palsy aged 10-15 years. The study will compare outcomes between standard NDT-Bobath therapy supplemented with exergaming in a sitting position and exergaming in a standing position. Postural stability, body composition, and functional parameters will also be assessed.
Participants will complete a socio-medical questionnaire and undergo baseline measurements of spinal mobility, cervical range of motion, postural stability (using Podoscan and Zebris platform), body height, and body composition (using SECA stadiometer and Tanita bioimpedance analyzer).
Read more
The intervention will last 3 months and include twice-weekly 60-minute therapy sessions. Group I will receive NDT-Bobath therapy supplemented with exergaming in a sitting position, while Group II will receive NDT-Bobath therapy with exergaming in a standing position.
After the intervention, participants will undergo post-intervention measurements and a follow-up evaluation three months later to assess the persistence of any changes.
Read the detailed description
This study aims to evaluate the effects of NDT-Bobath therapy supplemented with exergaming on spinal mobility in children with cerebral palsy (CP) aged 10-15 years. Based on these calculations, a representative study sample includes 42 participants.
Eligible participants are children diagnosed by a physician with spastic diplegia (G80.1) or spastic hemiplegia (G80.2), the two most common clinical phenotypes of CP, representing approximately 35% and 25% of cases, respectively. Participants will be randomly assigned to two intervention groups:
Group I: NDT-Bobath therapy supplemented with exergaming performed in a sitting position.
Group II: NDT-Bobath therapy supplemented with exergaming performed in a standing position.
Participants' data will only be included in the final analysis if their attendance at therapy sessions is at least 85%.
The study will be conducted in four stages:
Stage I - Pilot Study:
A pilot study with 15 participants (who will not participate in the main study) will determine the optimal duration for measuring center-of-pressure sway in children aged 10-15 with CP. Postural stability will be assessed using posturography, Podoscan, and the Zebris platform. Zebris measurements will be dynamic and last 30, 60, and 90 seconds. Baseline assessments will include:
Socio-medical questionnaire covering personal, medical, physiotherapy, educational data, orthopedic equipment usage, physical and therapeutic activities, and nutrition.
Lumbar and thoracic spinal mobility in sagittal and transverse planes and kinematic chain mobility (lumbar spine, pelvic girdle, and lower limbs) using the MyoMotion system.
Cervical spine active range of motion using the CROM device in sagittal, frontal, and horizontal planes.
Body height via SECA 213 stadiometer and body composition (general and segmental fat mass, lean mass, estimated muscle mass) via Tanita bioimpedance analyzer.
Stage II - Intervention:
The intervention program will last 3 months, with 60-minute sessions twice weekly at a collaborating rehabilitation center.
Group I (sitting exergaming): NDT-Bobath therapy with exercises for muscle tone normalization in the pelvic girdle, central stability enhancement including trunk rotation, and exercises for shoulder girdle tone normalization. Therapy sessions follow three core NDT principles: facilitation, stimulation, and communication. Exergaming will be performed in a seated position with hips, knees, and ankles at 90°, allowing gradual position changes between exercises to manage child concentration.
Group II (standing exergaming): NDT-Bobath therapy with similar exercises as Group I, but exergaming performed in a standing position with appropriate posture. Session structure includes adjustments for position changes and attention management.
Participants will be classified according to compensatory patterns:
Type A/A: symmetrical antigravity pattern
Type P/P: symmetrical progravity pattern
Type A/P: mixed antigravity/progravity pattern
Exergaming will use Kinect Therapy-Based Exergames with Microsoft Kinect.
Stage III - Post-intervention Assessment:
Spinal mobility (lumbar, thoracic, cervical) will be reassessed using the same instruments as in Stage I.
Stage IV - Follow-up:
A repeat assessment identical to Stage III will be conducted 3 months after the intervention to evaluate the persistence of therapeutic effects.
- Being tested
- NDT-Bobath Therapy, Sitting Exergaming, Standing Exergaming
- Keywords
- Cerebral palsy, Spinal mobility, NDT-Bobath therapy, Exergaming
- Medical subject headings
- Cerebral palsy, spastic, diplegic, Hemiplegia, Cerebral Palsy
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
NDT-Bobath TherapyOther
Also called Neurodevelopmental Treatment (Bobath Concept)
Standard NDT-Bobath neurodevelopmental therapy focusing on normalization of muscle tone in the pelvic and shoulder girdle, enhancement of central trunk stability including rotational control, and promotion of symmetrical posture and controlled movements according to NDT principles (facilitation, stimulation, communication). Dosage - 60-minute sessions, twice weekly, for 3 months.
Sitting ExergamingOther
Also called Seated Exergaming
Exergaming performed in a seated position using Kinect Therapy-Based Exergames. Participants sit on an adjustable chair with hips, knees, and ankles flexed at 90°. Exercises involve safe, non-impact, visually engaging three-dimensional trunk and limb movements, personalized to the child's functional level. Movements are synchronized with the MyoMotion system for monitoring. Dosage - 60-minute sessions, twice weekly, for 3 months (as part of combined therapy).
Standing ExergamingOther
Exergaming performed in a standing position using Kinect Therapy-Based Exergames, promoting weight-bearing and functional trunk and limb control. Exercises involve safe, visually engaging three-dimensional movements, personalized to the child's functional abilities. Movements are synchronized with the MyoMotion system for real-time monitoring. Dosage - 60-minute sessions, twice weekly, for 3 months (as part of combined therapy).
| Study group | Role | What they receive |
|---|---|---|
| NDT-Bobath + Sitting Exergaming | Experimental | Participants in this group will receive standard NDT-Bobath therapy supplemented with exergaming performed in a seated position. Therapy sessions will last 60 minutes, twice weekly, for 3 months.
The NDT-Bobath component focuses on:
Normalizing muscle tone in the pelvic and shoulder girdle Enhancing central trunk stability, including trunk rotation Promoting symmetrical posture and controlled movement according to NDT principles (facilitation, stimulation, communication)
The exergaming component will be performed while seated on a chair with adjustable height to achieve 90° flexion at hips, knees, and ankles. Exercises will engage three-dimensional trunk and limb movements, be visually engaging, and allow personalization according to each child's functional level. Exercises are safe, non-impact, and synchronized with the MyoMotion system for monitoring. Receives: Other: NDT-Bobath Therapy; Other: Sitting Exergaming |
| NDT-Bobath + Standing Exergaming | Experimental | Participants in this group will receive standard NDT-Bobath therapy supplemented with exergaming performed in a standing position. Therapy sessions will last 60 minutes, twice weekly, for 3 months.
The NDT-Bobath component focuses on:
Normalizing muscle tone in the pelvic and shoulder girdle Enhancing central trunk stability, including trunk rotation Promoting symmetrical posture and controlled movement according to NDT principles (facilitation, stimulation, communication)
The exergaming component will be performed in a standing position, promoting weight-bearing and functional trunk and limb control. Exercises engage three-dimensional movements, are visually appealing, and personalized according to the child's functional abilities. Exercise intensity is safe and designed to prevent injury, with position adjustments between exercises as needed. Exercises are synchronized with the MyoMotion system for real-time monitoring. Receives: Other: NDT-Bobath Therapy; Other: Standing Exergaming |
What is being measured
The primary outcome is the main question the study is designed to answer.
Cervical Spine Mobility
Change in active cervical spine range of motion in children with cerebral palsy aged 10-15 years, measured in sagittal, frontal, and transverse planes using the CROM device. Cervical flexion/extension, lateral flexion, and rotation are expressed in degrees.
Measured: Baseline, post-intervention (3 months), follow-up (6 months)
Thoracic Spine Mobility
Change in thoracic spine mobility measured as active range of motion and trunk rotation using the MyoMotion system. Measurements are expressed in degrees and reflect thoracic flexion/extension, lateral flexion, and rotational movements.
Measured: Baseline, post-intervention (3 months), follow-up (6 months)
Lumbar Spine Mobility
Change in lumbar spine mobility measured as active range of motion using the MyoMotion system. Lumbar flexion/extension, lateral flexion, and rotation are expressed in degrees.
Measured: Baseline, post-intervention (3 months), follow-up (6 months)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Feb 2026
- Study startFeb 2026 (estimated)
- Primary completionJun 2026 (estimated)
- Study completionJun 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Spastic Diplegia Cerebral PalsyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- The participants will be randomly assigned to one of two groups. Group I: NDT-Bobath therapy supplemented with exergaming performed in a sitting position using Kinect Therapy-Based Exergames. Group II: NDT-Bobath therapy supplemented with exergaming performed in a standing position using the same systems.
- Masking
- None (open label)
- Enrolment
- 42 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Wroclaw University of Health and Sport Sciences
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Aleksandra Kopaczyńska, Wroclaw University of Health and Sport Sciences
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07421505
- Sponsor's protocol ID
- WroclawUHSS Ethics (34/2025)
- Status last verified
- Feb 2026
- First submitted
- 28 Jan 2026
- Last updated
- 19 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided: At this time, a final decision has not been made regarding the sharing of de-identified individual participant data (IPD). Potentially shareable data would include de-identified demographic information and outcome data relevant to the primary and secondary endpoints of the study. The decision regarding IPD sharing will be made after completion of the study and final data analyses. This is due to the need to evaluate: * compliance with applicable data protection and privacy regulations, * limitations related to the informed consent obtained from participants, * potential contractual or institutional obligations, * the risk of participant re-identification despite data de-identification. Following study completion and publication of results, the possibility of sharing IPD will be reconsidered.
Study at a glance
From the registry record, last updated by the sponsor on 19 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Spinal Mobility in Children With Cerebral Palsy Undergoing NDT-Bobath Therapy and Exergaming-based Therapy
- ClinicalTrials.gov ID
- NCT07421505
- Acronym / sponsor ID
- WroclawUHSS Ethics (34/2025)
- Keywords
- Cerebral palsy, Spinal mobility, NDT-Bobath therapy, Exergaming
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 42 participants (estimated)
- Lead sponsor
- Wroclaw University of Health and Sport SciencesUniversity, hospital or other
- Study start
- Feb 2026 (estimated)
- Primary completion
- Jun 2026 (estimated)
- Study completion
- Jun 2026 (estimated)
- First posted
- 19 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to evaluate changes in spinal mobility in the cervical, thoracic, and lumbar regions in children with cerebral palsy aged 10-15 years. The study will compare outcomes between standard NDT-Bobath therapy supplemented with exergaming in a sitting position and exergaming in a standing position. Postural stability, body composition, and functional parameters will also be assessed.
Participants will complete a socio-medical questionnaire and undergo baseline measurements of spinal mobility, cervical range of motion, postural stability (using Podoscan and Zebris platform), body height, and body composition (using SECA stadiometer and Tanita bioimpedance analyzer).
The intervention will last 3 months and include twice-weekly 60-minute therapy sessions. Group I will receive NDT-Bobath therapy supplemented with exergaming in a sitting position, while Group II will receive NDT-Bobath therapy with exergaming in a standing position.
After the intervention, participants will undergo post-intervention measurements and a follow-up evaluation three months later to assess the persistence of any changes.
Detailed description
This study aims to evaluate the effects of NDT-Bobath therapy supplemented with exergaming on spinal mobility in children with cerebral palsy (CP) aged 10-15 years. Based on these calculations, a representative study sample includes 42 participants.
Eligible participants are children diagnosed by a physician with spastic diplegia (G80.1) or spastic hemiplegia (G80.2), the two most common clinical phenotypes of CP, representing approximately 35% and 25% of cases, respectively. Participants will be randomly assigned to two intervention groups:
Group I: NDT-Bobath therapy supplemented with exergaming performed in a sitting position.
Group II: NDT-Bobath therapy supplemented with exergaming performed in a standing position.
Participants' data will only be included in the final analysis if their attendance at therapy sessions is at least 85%.
The study will be conducted in four stages:
Stage I - Pilot Study:
A pilot study with 15 participants (who will not participate in the main study) will determine the optimal duration for measuring center-of-pressure sway in children aged 10-15 with CP. Postural stability will be assessed using posturography, Podoscan, and the Zebris platform. Zebris measurements will be dynamic and last 30, 60, and 90 seconds. Baseline assessments will include:
Socio-medical questionnaire covering personal, medical, physiotherapy, educational data, orthopedic equipment usage, physical and therapeutic activities, and nutrition.
Lumbar and thoracic spinal mobility in sagittal and transverse planes and kinematic chain mobility (lumbar spine, pelvic girdle, and lower limbs) using the MyoMotion system.
Cervical spine active range of motion using the CROM device in sagittal, frontal, and horizontal planes.
Body height via SECA 213 stadiometer and body composition (general and segmental fat mass, lean mass, estimated muscle mass) via Tanita bioimpedance analyzer.
Stage II - Intervention:
The intervention program will last 3 months, with 60-minute sessions twice weekly at a collaborating rehabilitation center.
Group I (sitting exergaming): NDT-Bobath therapy with exercises for muscle tone normalization in the pelvic girdle, central stability enhancement including trunk rotation, and exercises for shoulder girdle tone normalization. Therapy sessions follow three core NDT principles: facilitation, stimulation, and communication. Exergaming will be performed in a seated position with hips, knees, and ankles at 90°, allowing gradual position changes between exercises to manage child concentration.
Group II (standing exergaming): NDT-Bobath therapy with similar exercises as Group I, but exergaming performed in a standing position with appropriate posture. Session structure includes adjustments for position changes and attention management.
Participants will be classified according to compensatory patterns:
Type A/A: symmetrical antigravity pattern
Type P/P: symmetrical progravity pattern
Type A/P: mixed antigravity/progravity pattern
Exergaming will use Kinect Therapy-Based Exergames with Microsoft Kinect.
Stage III - Post-intervention Assessment:
Spinal mobility (lumbar, thoracic, cervical) will be reassessed using the same instruments as in Stage I.
Stage IV - Follow-up:
A repeat assessment identical to Stage III will be conducted 3 months after the intervention to evaluate the persistence of therapeutic effects.
Study design
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- The participants will be randomly assigned to one of two groups. Group I: NDT-Bobath therapy supplemented with exergaming performed in a sitting position using Kinect Therapy-Based Exergames. Group II: NDT-Bobath therapy supplemented with exergaming performed in a standing position using the same systems.
| Arm | Type | Receives |
|---|---|---|
| NDT-Bobath + Sitting Exergaming | Experimental | Other: NDT-Bobath Therapy, Other: Sitting ExergamingParticipants in this group will receive standard NDT-Bobath therapy supplemented with exergaming performed in a seated position. Therapy sessions will last 60 minutes, twice weekly, for 3 months. The NDT-Bobath component focuses on: Normalizing muscle tone in the pelvic and shoulder girdle Enhancing central trunk stability, including trunk rotation Promoting symmetrical posture and controlled movement according to NDT principles (facilitation, stimulation, communication) The exergaming component will be performed while seated on a chair with adjustable height to achieve 90° flexion at hips, knees, and ankles. Exercises will engage three-dimensional trunk and limb movements, be visually engaging, and allow personalization according to each child's functional level. Exercises are safe, non-impact, and synchronized with the MyoMotion system for monitoring. |
| NDT-Bobath + Standing Exergaming | Experimental | Other: NDT-Bobath Therapy, Other: Standing ExergamingParticipants in this group will receive standard NDT-Bobath therapy supplemented with exergaming performed in a standing position. Therapy sessions will last 60 minutes, twice weekly, for 3 months. The NDT-Bobath component focuses on: Normalizing muscle tone in the pelvic and shoulder girdle Enhancing central trunk stability, including trunk rotation Promoting symmetrical posture and controlled movement according to NDT principles (facilitation, stimulation, communication) The exergaming component will be performed in a standing position, promoting weight-bearing and functional trunk and limb control. Exercises engage three-dimensional movements, are visually appealing, and personalized according to the child's functional abilities. Exercise intensity is safe and designed to prevent injury, with position adjustments between exercises as needed. Exercises are synchronized with the MyoMotion system for real-time monitoring. |
Who may qualify
- Ages
- 6 to 18 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
Key inclusion criteria (8 listed)
- Written informed consent from parents/guardians and the child (if capable)
- GMFCS levels I-III (mild to moderate motor limitations)
- Ability to maintain standing position
- Ability to follow instructions and perform exercises
- No prior exergaming therapy
Key exclusion criteria (6 listed)
- GMFCS levels IV-V
- Orthopedic surgery within the past 12 months
- Seizure episodes within the past 6 months
- Cognitive or behavioral impairments preventing cooperation
- Severe spinal deformities (scoliosis >40° or other significant changes)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| NDT-Bobath TherapyAlso: Neurodevelopmental Treatment (Bobath Concept)Standard NDT-Bobath neurodevelopmental therapy focusing on normalization of muscle tone in the pelvic and shoulder girdle, enhancement of central trunk stability including rotational control, and promotion of symmetrical posture and controlled movements according to NDT principles (facilitation, stimulation, communication). Dosage - 60-minute sessions, twice weekly, for 3 months. | Other | NDT-Bobath + Sitting Exergaming, NDT-Bobath + Standing Exergaming |
| Sitting ExergamingAlso: Seated ExergamingExergaming performed in a seated position using Kinect Therapy-Based Exergames. Participants sit on an adjustable chair with hips, knees, and ankles flexed at 90°. Exercises involve safe, non-impact, visually engaging three-dimensional trunk and limb movements, personalized to the child's functional level. Movements are synchronized with the MyoMotion system for monitoring. Dosage - 60-minute sessions, twice weekly, for 3 months (as part of combined therapy). | Other | NDT-Bobath + Sitting Exergaming |
| Standing ExergamingExergaming performed in a standing position using Kinect Therapy-Based Exergames, promoting weight-bearing and functional trunk and limb control. Exercises involve safe, visually engaging three-dimensional movements, personalized to the child's functional abilities. Movements are synchronized with the MyoMotion system for real-time monitoring. Dosage - 60-minute sessions, twice weekly, for 3 months (as part of combined therapy). | Other | NDT-Bobath + Standing Exergaming |
Primary outcome
Cervical Spine Mobility
Time frame: Baseline, post-intervention (3 months), follow-up (6 months)
Change in active cervical spine range of motion in children with cerebral palsy aged 10-15 years, measured in sagittal, frontal, and transverse planes using the CROM device. Cervical flexion/extension, lateral flexion, and rotation are expressed in degrees.
Thoracic Spine Mobility
Time frame: Baseline, post-intervention (3 months), follow-up (6 months)
Change in thoracic spine mobility measured as active range of motion and trunk rotation using the MyoMotion system. Measurements are expressed in degrees and reflect thoracic flexion/extension, lateral flexion, and rotational movements.
Lumbar Spine Mobility
Time frame: Baseline, post-intervention (3 months), follow-up (6 months)
Change in lumbar spine mobility measured as active range of motion using the MyoMotion system. Lumbar flexion/extension, lateral flexion, and rotation are expressed in degrees.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Feb 2026.
- Individual participant dataSharing planned: Undecided. At this time, a final decision has not been made regarding the sharing of de-identified individual participant data (IPD). Potentially shareable data would include de-identified demographic information and outcome data relevant to the primary and secondary endpoints of the study. The decision regarding IPD sharing will be made after completion of the study and final data analyses. This is due to the need to evaluate: * compliance with applicable data protection and privacy regulations, * limitations related to the informed consent obtained from participants, * potential contractual or institutional obligations, * the risk of participant re-identification despite data de-identification. Following study completion and publication of results, the possibility of sharing IPD will be reconsidered.
Related trials for Spastic Diplegia Cerebral Palsy
Recruiting
Additional Effects on tDCS With AOT on Lower Limb Functions on Children With Diplegic CP
Diplegic Cerebral Palsy
Recruiting
Short-Term Effects of Manual Therapy Prior to Neuromotor Therapy in Children With Cerebral Palsy
Cerebral Palsy (CP), Unilateral Spastic Cerebral Palsy
Not yet recruiting
Dual-Task Training in Children With Spastic Diplegic Cerebral Palsy
Spastic Diplegia Cerebral Palsy
Not yet recruitingObservational study
Sleep Quality, Caregiver Burden, Stress, and Self-Efficacy in Parents of Children With Spastic Diplegic Cerebral Palsy: A Comparison by Night Orthosis Use
Cerebral Palsy, Sleep Disorders
Recruiting
Effects of Transcranial Direct Current Stimulation Combined With Virtual Reality on Gait and Self-Esteem in Children With Spastic Cerebral Palsy
Spastic Diplegic Cerebral Palsy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing NDT-Bobath Therapy, Sitting Exergaming and Standing Exergaming in people with Spastic Diplegia Cerebral Palsy and Spastic Hemiplegia, run by Wroclaw University of Health and Sport Sciences at 2 sites in Poland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 19 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Poland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Aleksandra Kopaczyńska, Master of Science (+48601157773, aleksandra.kopaczynska@awf.wroc.pl), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Cervical Spine Mobility (time frame: Baseline, post-intervention (3 months), follow-up (6 months)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Feb 2026.